Article

Techniques: an update on surgical decompression for thyroid eye disease

Currently, surgeons are employing combination techniques of bone and fat decompression to treat thyroid eye disorders, depending on the clinical situation. Prospective studies are needed to establish the ideal operative approach to minimize postoperative complications with the best cosmetic outcome in mind. Despite the multiple options available, it is most important to tailor the surgical approach to meet the individual needs of the patient.

Key Points

Increasing orbital volume

Conventional methods of bony decompression target the medial wall and orbital floor. Advantages of the inferomedial approach include a large volume decompression, up to 15 ml in cadaveric studies, with a relatively small incision.3 Moreover, the medial wall is targeted in cases of progressive optic neuropathy, in which the orbital apex must be adequately decompressed.

Though inferomedial decompression provides excellent volume enhancement, it is associated with a high incidence of postoperative diplopia, up to 60% in some case series.7 This largely has been attributed to asymmetric decompression, resulting in inferomedial displacement of the globe. Multiple strategies have been proposed to minimize postoperative diplopia and hypoglobus, including preservation of the medial-orbital strut, which provides bony support to the orbit and serves as a site of attachment of multiple globe-supporting ligamentous structures.8

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.